This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): 4SC-202
Description: 4SC-202 is an orally administered, selective histone deacetylase (HDAC) inhibitor which is also characterized by an anti-mitotic mechanism of action.
Additional information available to subscribers only: